CVS, UnitedHealth, Cigna sue to block FTC case over insulin prices
CVS Health, UnitedHealth Group, and Cigna have sued the Federal Trade Commission (FTC), claiming its case against drug supply chain middlemen over high insulin prices is unconstitutional. The FTC accused these companies’ pharmacy benefit managers (PBMs)—CVS’s Caremark, Cigna’s Express Scripts, and UnitedHealth’s Optum Rx—of inflating insulin costs through a rebate system that boosts their profits. The lawsuit, filed in Missouri, argues that the FTC’s administrative … Continue reading CVS, UnitedHealth, Cigna sue to block FTC case over insulin prices
